Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Baidu has reported for Q3 2023

11/21/23 BIDU

Shareholders of Rostelecom approved dividends for 2022

11/21/23 RTKM

UTair passenger traffic on airplanes in January-October increased by 9.8%

11/21/23 UTAR

Magnit will expand the network of MCosmetic stores in Uzbekistan

11/21/23 MGNT

Astra may hold an SPO in the next two years

11/21/23 ASTR

Polymetal launched equipment from Turkey at Prognoz field

11/21/23 POLY

UWC completed the collection of applications for participation in the additional share issue

11/20/23 UWGN

Sanctions against Arctic LNG-2 may deprive Novatek of 4% of market

11/20/23 NVTK

Xiaomi has reported for 9 months of 2023

11/20/23 1810

VEON reported for 9 months of 2023

11/20/23 VEON